(Reuters) -Johnson & Johnson said on Tuesday it will withdraw a device to treat acid reflux disease from certain markets outside the United States, citing commercial reasons. The company has decided ...

One in five Americans suffers from gastroesophageal reflux disease (GERD), known colloquially as acid reflux. Acid reflux is a digestive disorder in in which acid backs up from the stomach into the ...

Mayo Clinic in Jacksonville, Fla., has announced it will be one of the first healthcare organizations in the United States to offer the LINX Reflux Management System to treat gastroesophageal reflux ...

The FDA’s Gastroenterology-Urology Devices Panel voted unanimously that LINX’s Reflux Management System, a laparoscopically implanted device designed to treat gastroesophageal reflux disease, has a ...

FDA has announced it has approved Torax Medical’s LINX Reflux Management System for treatment of gastroesophageal reflux disease, according to a news release. The LINX Reflux Management System is a ...

If you’ve ever felt a burning sensation in your chest or throat after eating or drinking, you know how uncomfortable acid reflux can be. For many, this common digestive discomfort happens infrequently ...

Johnson & Johnson (NYSE:JNJ) will withdraw its LINX Reflux Management System—a device used to treat acid reflux disease—from markets outside the U.S. from March, according to a Bloomberg report that ...

If you’ve ever felt like your chest is on fire after a meal, you’re no stranger to acid reflux. While experiencing occasional reflux is normal, recurrent acid reflux is not. And it may lead to other ...

Johnson & Johnson (NYSE:JNJ) is one of the best conservative stocks to buy now. On September 23, the company announced plans to withdraw the LINX Reflux Management System in certain countries. The ...